RHON-KLINIKUM AG (0NQH) Price & Analysis

0 Followers

0NQH Stock Chart & Stats

€13.20

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€13.20

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€11.50 - €15.30

Previous CloseN/A

Volume0.00

Average Volume (3M)0.00

Market Cap

€970.61M

Enterprise Value€889.42M

Total Cash (Recent Filing)€556.55M

Total Debt (Recent Filing)€121.88M

Price to Earnings (P/E)22.7

Beta-0.23

Next Earnings

Nov 05, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.64

Shares Outstanding66,962,470

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio-1.22

Price to Book (P/B)0.64

Price to Sales (P/S)0.44

P/FCF Ratio-24.57

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.64

Revenue Forecast (FY)€1.79B

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage and a growing equity base provide RHÖN-KLINIKUM with resilience to earnings volatility and room to fund hospital operations. Debt reduction also limits financing strain, supporting continuity of care and strategic flexibility over the next several quarters.

Hospital Revenue ExpansionStrong revenue expansion in 2023 and 2025 shows the hospital business can achieve meaningful growth, even though results are uneven. Sustained demand for inpatient and outpatient medical care could support a larger operating base and future earnings recovery.

Proven Prior Cash GenerationThe company generated substantial operating and free cash flow in the two years before 2025, demonstrating that its healthcare operations have previously converted activity into liquidity. This history provides a foundation for funding investment and maintaining financial resilience.

Bears Say

Sharp EBIT DeclineThe steep EBIT decline despite revenue growth indicates that additional activity is not currently translating into comparable operating profit. If this pattern persists, it could weaken earnings quality, reduce internal funding capacity, and limit the benefits of scale.

Negative Latest Free Cash FlowNegative free cash flow in the latest year reduces financial flexibility and may require greater reliance on existing liquidity or financing to support investment. Persistent weak cash conversion would make it harder to fund hospital needs while preserving balance-sheet strength.

Thin And Uneven ProfitabilityLow margins leave limited protection against operating cost pressure, while the 2024 revenue decline shows that performance can be uneven. This combination makes earnings more vulnerable to execution challenges and increases the importance of restoring durable operating efficiency.

0NQH FAQ

What was RHON-KLINIKUM AG’s price range in the past 12 months?

RHON-KLINIKUM AG lowest share price was €11.50 and its highest was €15.30 in the past 12 months.

What is RHON-KLINIKUM AG’s market cap?

RHON-KLINIKUM AG’s market cap is €970.61M.

When is RHON-KLINIKUM AG’s upcoming earnings report date?

RHON-KLINIKUM AG’s upcoming earnings report date is Nov 05, 2026 which is in 22 days.

How were RHON-KLINIKUM AG’s earnings last quarter?

RHON-KLINIKUM AG released its earnings results on Aug 06, 2026. The company reported €0.135 earnings per share for the quarter.

Is RHON-KLINIKUM AG overvalued?

According to Wall Street analysts RHON-KLINIKUM AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does RHON-KLINIKUM AG pay dividends?

RHON-KLINIKUM AG does not currently pay dividends.

What is RHON-KLINIKUM AG’s EPS estimate?

RHON-KLINIKUM AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does RHON-KLINIKUM AG have?

RHON-KLINIKUM AG has 66,962,470 shares outstanding.

What happened to RHON-KLINIKUM AG’s price movement after its last earnings report?

RHON-KLINIKUM AG reported an EPS of €0.135 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of RHON-KLINIKUM AG?

Currently, no hedge funds are holding shares in GB:0NQH

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

RHON-KLINIKUM AG Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

3.18%

Trailing 12-Months

Asset Growth

-2.06%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

RHON-KLINIKUM AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, delivers extensive healthcare services across Germany, encompassing inpatient, day-patient, and outpatient treatment models. The company's hospitals provide a broad spectrum of medical and surgical care, including cardiovascular rehabilitation, specialized hand and trauma surgery, neurological and psychosomatic treatments, addiction therapy, ophthalmology, and dentistry. They also address conditions affecting the thoracic region, lungs, and vascular system, offer oncology services, and manage neurological conditions, spinal column and joint issues, as well as heart diseases. The organization operates eight hospitals, providing a total of 5,420 beds or patient slots across five distinct medical locations. RHÖN-KLINIKUM is headquartered in Bad Neustadt an der Saale, Germany.